Case report: Anaphylaxis following cystoscopy with equipment sterilized with Cidex® OPA (Ortho-phthalaldehyde): A review of two cases

Journal of Endourology

Volumn 22, Issue 9, 2008, Pages 2181-2184

  Cooper, Daniel E ^a   White, Andrew A ^a   Werkema, Angelina N ^a   Auge, Brain K ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHTHALALDEHYDE; GLUTARALDEHYDE;

AGED; ANAMNESIS; ANAPHYLAXIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CYSTOSCOPY; ENDOSCOPY; HUMAN; INSTRUMENT STERILIZATION; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; ARTICLE; CHEMICALLY INDUCED DISORDER; CYSTOSCOPE; MIDDLE AGED; SKIN TEST;

AGED; ANAPHYLAXIS; CYSTOSCOPES; GLUTARAL; HUMANS; MALE; MIDDLE AGED; O-PHTHALALDEHYDE; SKIN TESTS; STERILIZATION;

EID: 52449116570     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2007.0358     Document Type: Conference Paper

References (15)

1. Owings MF, Kozak LJ. Ambulatory and inpatient procedures in the United States, 1996. National Center for Health Statistics. Vital Health Stat 1998;13:139.
2. Akamatsu T, Minemoto M, Uyeda M. Evaluation of the antimicrobial activity and materials compatibility of orthophthalaldehyde as a high-level disinfectant. J Int Med Res 2005;33:2.
3. Cooke RP, Goddard SV, Whymant-Morris A, et al. An evaluation of Cidex OPA (0.55% ortho-phthalaldehyde) as an alternative to 2% glutaraldehyde for high-level disinfection of endoscopes. J Hosp Infect 2003;54(3):226-231.
4. Walsh SE, Maillard JY, Simons C, et al. Studies on the mechanisms of the antibacterial action of ortho-phthalaldehyde. J Appl Microbiol 1999;87(5):702-710.
5. Sokol WN. Nine episodes of anaphylaxis following cystoscopy caused by Cidex OPA (ortho-phthalaldehyde) high-level disinfectant in 4 patients after cytoscopy. J Allergy Clin Immunol 2004;114(2):392-397.
6. Venticinque SG, Kashyap VS, O'Connell RJ. Chemical burn injury secondary to intraoperative transesophageal echocardiography. Anesth Analg 2003;97(5):1260-1261.
7. Rideout K, Teschke K, Dimich-Ward H, et al. Considering risks to healthcare workers from glutaraldehyde alternatives in high-level disinfection. J Hosp Infect, 2005;59(1):4-11.
8. Rittenbury MS, Hench ME. Preliminary evaluation of an activated glutaraldehyde solution for cold sterilization. Ann Surg 1965;161:127-130.
9. Lane V, McKeever JD, Fallon M. Buffered glutaraldehyde (Cidex). A new disinfectant specially useful in urology. J Ir Med Assoc 1966;58(346):131-132.
10. Hession SM. Endoscope disinfection by ortho-phthalaldehyde in a clinical setting: an evaluation of reprocessing time and costs compared with glutaraldehyde. Gastroenterol Nurs 2003;26(3):110-114.
11. Fraud S, Maillard JY, Russell AD. Comparison of the mycobactericidal activity of ortho- phthalaldehyde, glutaraldehyde and other dialdehydes by a quantitative suspension test. J Hosp Infect 2001;48(3):214-221.
12. Bernstein DI. Occupational asthma caused by exposure to low-molecular-weight chemicals. Immunol Allergy Clin North Am 2003;23(2):221-234.
13. Wetter DA, Davis MD, Yiannias JA, et al. Patch test results from the Mayo Clinic Contact Dermatitis Group, 1998-2000. J Am Acad Dermatol 2005;53(3):416-421.
14. Suzukawa M, Yamaguchi M, Komiya A, et al. Ortho-phthalaldehyde-induced anaphylaxis after laryngoscopy. J Allergy Clin Immunol 2006;117(6):1500-1501.
15. Safety Alert. Labeling change to CIDEX OPA solution instructions for use. First notification. Advanced Sterilzation Products (a division of Johnson & Johnson®); April, 2004 (http://www.sterrad.com/Products_&_Services/ CIDEX/CIDEX_OPA/LabelChange.asp)